Regenerative medicine: what it is, what it covers, and who it suits
Regenerative medicine is the branch of medicine that aims to repair, replace or restore damaged cells, tissues and organs rather than only manage symptoms. It spans mesenchymal stem cell therapy, exosome therapy, platelet-rich plasma (PRP), growth factors and tissue engineering.
What is regenerative medicine?
Regenerative medicine uses biological material — cells, cell-derived vesicles, plasma concentrates or engineered scaffolds — to influence the body's own repair processes. Instead of replacing a joint or suppressing an immune response indefinitely, the goal is to modulate inflammation, improve the local tissue environment and support functional recovery.
At StemCell Longevita in Istanbul, regenerative medicine is delivered as a physician-led pathway: records review first, then candidacy, then an individualised plan. See our clinical decision guides for how those judgements are made.
- Mesenchymal stem cell (MSC) therapy — immunomodulatory and trophic support
- Exosome therapy — a cell-free signalling approach
- Platelet-rich plasma (PRP) — autologous growth factor concentrate
- Induced pluripotent stem cells (iPSCs) — largely research-stage
- Tissue engineering and biological scaffolds — combining cells with structural support
What is regenerative medicine?
Regenerative medicine is the field aiming to restore function to damaged tissue rather than only relieve symptoms. It covers cell therapies, cell-derived products such as exosomes, biomaterials, gene-modified cells and tissue engineering. A small number of these are licensed treatments; most remain investigational, which is why clinics should state clearly which category any offered treatment falls into.
Key facts
- Includes
- Cell therapy, exosomes, biomaterials, tissue engineering
- Licensed examples
- Haematopoietic transplantation, selected CAR-T and ATMP products
- Investigational
- Most MSC and exosome indications
What we know
- Some regenerative therapies are fully approved and standard of care.
What remains uncertain
- The majority of advertised regenerative treatments are not approved for those indications.
Medically reviewed questions
This summary is general medical information, not medical advice, and not a promise of benefit. Figures are quoted ranges, confirmed in writing after a medical review.
Medically reviewed by: Prof. Dr. Erdal Karaöz · Last updated: · Editorial and evidence policy
Which conditions are discussed in a regenerative medicine consultation?
Patients most often ask about orthopaedic wear and injury, neurological conditions, autoimmune disease, metabolic disease and healthy-ageing goals. Each has a different evidence base and a different realistic expectation. Browse the full condition list for pathway-specific detail.
- Osteoarthritis, cartilage and joint pain
- Neurological conditions including MS, Parkinson's and cerebral palsy
- Autoimmune conditions such as lupus, Crohn's and psoriasis
- Metabolic conditions including type 2 diabetes support
- Healthy ageing and cellular rejuvenation
How strong is the evidence?
Evidence quality varies sharply by indication and by product. Some orthopaedic and graft-versus-host-disease applications have randomised data; many others remain investigational. We publish what we rely on in our scientific evidence review and set out sourcing, sterility and viability documentation under credentials and quality.
Regenerative medicine in Turkey
Istanbul is one of the main destinations for international patients seeking regenerative medicine, largely because GMP laboratory capacity, hospital care and coordinated travel sit close together. Practical comparisons — inclusions, timing and follow-up — are covered in our Turkey treatment cost guide and the Istanbul treatment hub.
Frequently asked questions
Is regenerative medicine the same as stem cell therapy?
No. Stem cell therapy is one part of regenerative medicine. The field also includes exosomes, PRP, growth factors, gene-based approaches and tissue engineering.
Is regenerative medicine a cure?
It should not be presented as a cure. For most conditions the realistic objective is symptom modification, functional improvement or slower progression, assessed over a defined follow-up period.
Who is not a candidate?
Active malignancy, uncontrolled infection, severe organ failure and some pregnancy-related circumstances usually make treatment inappropriate. A medical review always precedes any plan.
Ask whether this is right for you
Share your diagnosis and recent records. Our medical team in Istanbul reviews candidacy, alternatives and realistic goals before any treatment plan is proposed.
Request a free medical review